The store will not work correctly in the case when cookies are disabled.
We use cookies to make your experience better.To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies.Learn more.
Scott, Michael et al. (2020) Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies. Cytotherapy.
Scott, Michael et al. (2020) Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies. Cytotherapy.
We're sorry, an error has occurred while generating this content.
